Trillium Therapeutics Inc (TRIL.OQ)
6.40USD
25 Apr 2018
$-0.25 (-3.76%)
$6.65
$6.60
$6.60
$6.30
6,783
15,846
$13.30
$4.10
Tue, Apr 10 2018
BRIEF-Trillium Therapeutics Provides Update On Its Clinical Programs
* TRILLIUM THERAPEUTICS PROVIDES UPDATE ON ITS TTI-621 AND TTI-622 CLINICAL PROGRAMS
BRIEF-Trillium Therapeutics' TTI-621 Receives Orphan Drug Designation For Treatment Of Cutaneous T-Cell Lymphoma
* TRILLIUM THERAPEUTICS' TTI-621 RECEIVES ORPHAN DRUG DESIGNATION FOR TREATMENT OF CUTANEOUS T-CELL LYMPHOMA Source text for Eikon: Further company coverage:
BRIEF-Trillium Therapeutics Reports Annual 2017 Financial And Operating Results
* TRILLIUM THERAPEUTICS REPORTS ANNUAL 2017 FINANCIAL AND OPERATING RESULTS
BRIEF-Trillium Therapeutics Inc Files For Mixed Shelf Of Upto $150 Mln
* TRILLIUM THERAPEUTICS INC FILES FOR MIXED SHELF OF UPTO $150 MILLION - SEC FILING Source text : http://bit.ly/2jZxGi0 Further company coverage:
BRIEF-Matrix Capital Management Co Reports A 16.5 Pct Passive Stake In Trillium Therapeutics
* MATRIX CAPITAL MANAGEMENT COMPANY LP REPORTS A 16.5 PCT PASSIVE STAKE IN TRILLIUM THERAPEUTICS INC AS OF NOV 30 - SEC FILING Source text: (http://bit.ly/2yOHuTW) Further company coverage:
BRIEF-Trillium announces private placement to fund development of cancer drugs
* Trillium Therapeutics - entered into subscription agreements for sale of 1.95 million shares & 400,000 Series II non-voting convertible first preferred shares
BRIEF-Trillium Therapeutics reports Q3 results
* Trillium Therapeutics reports third quarter 2017 financial and operating results
- Your Daily Pharma Scoop: vTv Therapeutics Plunges, Spectrum Provides Updated Data, Selecta Sees Pullback On Data
- Surface Oncology Proposes IPO Terms
- Surface Oncology Files For $75 Million IPO
- Your Daily Pharma Scoop: Arena Soars, Roche Data, GlaxoSmithKline Commences Study
- Trillium Therapeutics (TRIL) Presents At 38th Annual Cowen and Company Healthcare Conference - Slideshow
- U.S. Biotech/Pharma Sector Daily Observations Letter: March 14, 2018